MedTrace Logo

Characterization of Cancer Tissue Using 3D Biosynthetic Material

NCT02678078 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-05-06

No results posted yet for this study

Summary

Characterization of Cancer Tissue Using 3D Biosynthetic Materials. Using liver biopsy from stage 4 cancer patients, the investigators will evaluate and characterize the metastatic cells.

Conditions

Interventions

PROCEDURE

Analyzing biopsy samples

Analyzing biopsy samples that is preformed as part of the patient treatment.

Sponsors & Collaborators

  • Rambam Health Care Campus

    collaborator OTHER

  • Technion, Israel Institute of Technology

    lead OTHER

Principal Investigators

  • Dror seliktar, Prof · Technion, Israel Institute of Technology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02678078 on ClinicalTrials.gov